Skip to content
  1. Home
  2. Medications & hormones
  3. Naproxen

Naproxen

Longer-acting NSAID, typically twice daily rather than every few hours.

Medications & hormones

Recovery & healing

Research records

Historical source snapshot. Not freshly verified, not a recommendation. Study findings, community accounts and app defaults are not interchangeable.

Publication suitability · 2026-10-15: Historical reference only; not a clinical verification. Clinical, regulatory, efficacy, safety and dose claims are not independently established by this review.

Naproxen

Longer-acting NSAID, typically twice daily rather than every few hours.

Evidence category: Regulator / guideline. This describes the source category, not approval or certainty.

Regulatory statement in source: FDA-approved.

Naproxen is a non-steroidal anti-inflammatory drug. A standard clinical reference lists FDA-approved uses including acute gout, ankylosing spondylitis, bursitis, tendonitis, osteoarthritis, rheumatoid arthritis, pain and period pain. It blocks cyclooxygenase enzymes and is described as a first-line option for several painful inflammatory conditions. Like other NSAIDs it carries risks of stomach bleeding, kidney problems and cardiovascular events. The second source is a review of back-pain treatment options.

Benefits reported in the imported source

  • Gout, arthritis, tendonitis, bursitis, pain, period pain and fever.
  • Described as a first-line option for several painful inflammatory conditions

Risks and limits

  • Like other anti-inflammatories it carries stomach bleeding, kidney and cardiovascular risks

Source bottom line: An approved anti-inflammatory painkiller with a well-known profile of stomach, kidney and heart risks.

Uncertainty: Reference information only. Not medical advice.

Study protocols — reports, not instructions

adults and children 12 and over with minor aches, pains or fever, per the US over-the-counter label

Reported regimen
1 caplet orally every 8 to 12 hours with a full glass of water; 2 caplets allowed in the first hour; no more than 3 caplets in 24 hours
Duration
ongoing while symptoms last, per the label; stop after 10 days for pain or 3 days for fever unless a doctor says otherwise
Reported outcome
The label states this temporarily relieves minor arthritis pain, muscular aches, backache, menstrual cramps, headache and toothache, and reduces fever.
Source
Aleve (naproxen sodium) — US label (DailyMed)
Claim provenance

evidence.json#/catalog:medication:naproxen/protocols/0

Community and practice descriptions

Accounts of a practice are not evidence of safety or effectiveness. Words such as “standard”, “safe” or “recommended” describe the source account, not verified consensus or this wiki’s advice. Commercial and self-published citations are retained for traceability, not vendor endorsement or independent clinical corroboration.

Historical research outcome: no-verified-description · 2026-10-06

No suitable community description was independently verified in these checks. The entry remains empty; this does not establish that no practice exists elsewhere. The proposed text only lists available dosage forms, not a reported community routine.

Pharmacokinetic context

Historical half-life estimate: 14 hours. FDA label; 12-17 h Population/route context and estimates may differ. This is not a schedule or a verified human dosing rule.

Source references

Snapshot provenance

Source ID: catalog:medication:naproxen. Commit: adc7684614f9439b41d91a3312b62e7982c7e20e. Review state: historical-not-reverified. Authored links are retained separately from the canonical evidence links in the public data. App templates/defaults and rejected drafts are archived, not deployed.

Related entries and components

None listed.